Medrxcol: what changed
Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
Medrxcol
Largest movements
- Cash -€458,932
down €458,932 (-89.6%), from €512,459 to €53,527
mainly Other debts (-€369,023) and Contributions, distributions and other (-€155,000)
- Current investments +€52,000
up €52,000 (+39.4%), from €132,012 to €184,012
- Tangible fixed assets -€9,110
down €9,110 (-22.9%), from €39,801 to €30,691
- Other debts -€369,023
down €369,023 (-75.9%), from €486,428 to €117,404
- Tax, wage and social debts -€41,409
down €41,409 (-88.2%), from €46,969 to €5,560
- Gross operating margin +€4,954
up €4,954 (+2.3%), from €211,730 to €216,684
- Depreciation +€3,360
up €3,360 (+58.4%), from €5,750 to €9,110
- Taxes +€3,333
up €3,333 (+7.2%), from €46,604 to €49,937
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €702,754 | €292,556 | -€410,198 | -58.4% |
| Fixed assets | 21/28 | €39,801 | €30,691 | -€9,110 | -22.9% |
| Tangible fixed assets | 22/27 | €39,801 | €30,691 | -€9,110 | -22.9% |
| Furniture and vehicles | 24 | €39,801 | €30,691 | -€9,110 | -22.9% |
| Current assets | 29/58 | €662,952 | €261,865 | -€401,087 | -60.5% |
| Amounts receivable within one year | 40/41 | €1,532 | €3,595 | +€2,063 | +134.6% |
| Other amounts receivable | 41 | €1,532 | €3,595 | +€2,063 | +134.6% |
| Current investments | 50/53 | €132,012 | €184,012 | +€52,000 | +39.4% |
| Cash at bank and in hand | 54/58 | €512,459 | €53,527 | -€458,932 | -89.6% |
| Deferred charges and accrued income | 490/1 | €16,949 | €20,731 | +€3,782 | +22.3% |
| Total equity and liabilities | 10/49 | €702,754 | €292,556 | -€410,198 | -58.4% |
| Equity | 10/15 | €167,912 | €169,399 | +€1,487 | +0.9% |
| Contributions | 10/11 | €1,400 | €1,400 | = | 0.0% |
| Reserves | 13 | €164,500 | €164,500 | = | 0.0% |
| Distributable reserves | 133 | €164,500 | €164,500 | = | 0.0% |
| Profit (loss) carried forward | 14 | €2,012 | €3,499 | +€1,487 | +73.9% |
| Amounts payable | 17/49 | €534,842 | €123,157 | -€411,684 | -77.0% |
| Amounts payable within one year | 42/48 | €534,842 | €123,157 | -€411,684 | -77.0% |
| Trade debts | 44 | €1,445 | €193 | -€1,253 | -86.7% |
| Suppliers | 440/4 | €1,445 | €193 | -€1,253 | -86.7% |
| Taxes, remuneration and social security | 45 | €46,969 | €5,560 | -€41,409 | -88.2% |
| Taxes | 450/3 | €46,969 | €5,560 | -€41,409 | -88.2% |
| Other amounts payable | 47/48 | €486,428 | €117,404 | -€369,023 | -75.9% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €5,750 | €9,110 | +€3,360 | +58.4% |
| Other operating charges | 640/8 | €1,304 | €851 | -€453 | -34.7% |
| Gross operating margin | 9900 | €211,730 | €216,684 | +€4,954 | +2.3% |
| Operating profit (loss) | 9901 | €204,677 | €206,723 | +€2,046 | +1.0% |
| Financial income | 75/76B | €417 | - | -€417 | |
| Recurring financial income | 75 | €417 | - | -€417 | |
| Financial charges | 65/66B | €76 | €299 | +€222 | +292.0% |
| Recurring financial charges | 65 | €76 | €299 | +€222 | +292.0% |
| Profit (loss) for the period before taxes | 9903 | €205,017 | €206,424 | +€1,407 | +0.7% |
| Income taxes | 67/77 | €46,604 | €49,937 | +€3,333 | +7.2% |
| Profit (loss) for the period | 9904 | €158,413 | €156,487 | -€1,926 | -1.2% |
| Profit (loss) for the period to be appropriated | 9905 | €158,413 | €156,487 | -€1,926 | -1.2% |
Source: filed annual accounts (NBB), fiscal years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 9 October 2026 via checked.be.